Trial Profile
Randomised Control Study for Inactive Chronic Hepatitis B Patients With Low Viral Load, With Peg-Interferon (INACTIVE)
Status:
Active, no longer recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary)
- Indications Hepatitis B
- Focus Proof of concept; Therapeutic Use
- Acronyms INACTIVE
- 14 Mar 2019 Planned End Date changed from 1 Dec 2017 to 1 Aug 2019.
- 14 Mar 2019 Planned primary completion date changed from 1 Oct 2017 to 1 Aug 2019.
- 14 Mar 2019 Status changed from recruiting to active, no longer recruiting.